S
Salarius Pharmaceuticals (SLRX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Salarius Pharmaceuticals (SLRX)
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing effective treatments for cancers with unmet medical needs. It is developing treatments for cancers caused by dysregulated gene expressi... Read more
- USD0.81
- USD0.82
- USD0.79
- USD7.20
- 20.40%
- --
- 16.80k
- 36.85k
- 2M
- 0.45
- -79.40%
Stock News
yesterday
Jim Cramer explains how bonds shaped Tuesday's market action
CNBC
yesterday
Why Home Depot’s approach to prices and tariffs will ‘likely play better’ to Trump administration
MarketWatch
yesterday
S&P 500's win steak may end — but, our newest stock gets a double-dose of good news
CNBC
yesterday
NFL's Goodell says the league could more than double international games in the coming years
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
